MODERN POSSIBILITIES OF THERAPY WITH INHIBITORS OF CONTROL POINTS IN METASTATIC UROTHELIAL CANCER

For a long time, chemotherapy remained the main treatment option for metastatic urothelial carcinoma (mUC). Over the past year, there have been revolutionary changes associated with the approval of five new drugs aimed at blocking the interaction between the surface protein of T-lymphocytes PD-1 and...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: R. A. Gafanov, S. V. Garmash, I. B. Kravtsov, S. V. Fastovets
Formato: Artigo
Idioma:Russo
Publicado: QUASAR, LLC 2018-03-01
Series:Issledovaniâ i Praktika v Medicine
Assuntos:
bladder cancer
pd-1
pd-l1
immunotherapy
atezolizumab
nivolumab
pembrolizumab
avelumab
durvalumab
Acceso en liña:https://www.rpmj.ru/rpmj/article/view/246
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares